Literature DB >> 26468418

Loss of ARID1A Expression in Gastric Cancer: Correlation with Mismatch Repair Deficiency and Clinicopathologic Features.

Kyung-Ju Kim1, Hae Yoen Jung1, Mee-Hye Oh1, Hyundeuk Cho2, Ji-Hye Lee1, Hyun Ju Lee1, Si-Hyong Jang1, Moon Soo Lee3.   

Abstract

PURPOSE: The AT-rich interactive domain 1A (ARID1A) gene encodes BRG1-associated factor 250a, a component of the SWItch/Sucrose NonFermentable chromatin remodeling complex, which is considered a tumor suppressor in many tumors. We aimed to investigate the prognostic significance of ARID1A expression in gastric cancers and explore its relationship with clinicopathologic parameters such as mismatch repair protein expression.
MATERIALS AND METHODS: Four tissue microarrays were constructed from 191 resected specimens obtained at Soonchunhyang University Cheonan Hospital from 2006 to 2008. Nuclear expression of ARID1A was semiquantitatively assessed and binarized into retained and lost expression.
RESULTS: Loss of ARID1A expression was observed in 62 cases (32.5%). This was associated with more frequent vascular invasion (P=0.019) and location in the upper third of the stomach (P=0.001), and trended toward more poorly differentiated subtypes (P=0.054). ARID1A loss was significantly associated with the mismatch repair-deficient phenotype (P=0.003). ARID1A loss showed a statistically significant correlation with loss of MLH1 (P=0.001) but not MSH2 expression (P=1.000). Kaplan-Meier survival analysis showed no statistically significant difference in overall survival; however, patients with retained ARID1A expression tended to have better overall survival than those with loss of ARID1A expression (P=0.053). In both mismatch repair-deficient and mismatch repair-proficient groups, survival analysis showed no differences related to ARID1A expression status.
CONCLUSIONS: Our results demonstrated that loss of ARID1A expression is closely associated with the mismatch repair-deficient phenotype, especially in sporadic microsatellite instability-high gastric cancers.

Entities:  

Keywords:  ARID1A; DNA Mismatch repair; Microsatellite instability; Stomach neoplasms; Survival

Year:  2015        PMID: 26468418      PMCID: PMC4604335          DOI: 10.5230/jgc.2015.15.3.201

Source DB:  PubMed          Journal:  J Gastric Cancer        ISSN: 1598-1320            Impact factor:   3.720


  24 in total

Review 1.  The utility of immunohistochemical detection of DNA mismatch repair gene proteins.

Authors:  Jinru Shia; Nathan A Ellis; David S Klimstra
Journal:  Virchows Arch       Date:  2004-09-29       Impact factor: 4.064

2.  Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers.

Authors:  Kyung-Ju Kim; Kyu Sang Lee; Hwa Jin Cho; Young Hoon Kim; Han Kwang Yang; Woo Ho Kim; Gyeong Hoon Kang
Journal:  Hum Pathol       Date:  2013-12-12       Impact factor: 3.466

Review 3.  Causes and consequences of microsatellite instability in gastric carcinogenesis.

Authors:  Sérgia Velho; Maria Sofia Fernandes; Marina Leite; Ceu Figueiredo; Raquel Seruca
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

Review 4.  The emerging roles of ARID1A in tumor suppression.

Authors:  Ren-Chin Wu; Tian-Li Wang; Ie-Ming Shih
Journal:  Cancer Biol Ther       Date:  2014-03-11       Impact factor: 4.742

5.  ARID1A expression in gastric adenocarcinoma: clinicopathological significance and correlation with DNA mismatch repair status.

Authors:  Ryo Inada; Shigeki Sekine; Hirokazu Taniguchi; Hitoshi Tsuda; Hitoshi Katai; Toshiyoshi Fujiwara; Ryoji Kushima
Journal:  World J Gastroenterol       Date:  2015-02-21       Impact factor: 5.742

6.  ARID1A: a potential prognostic factor for breast cancer.

Authors:  Jing Zhao; Caigang Liu; Zuowei Zhao
Journal:  Tumour Biol       Date:  2014-01-16

7.  ARID1A immunohistochemistry improves outcome prediction in invasive urothelial carcinoma of urinary bladder.

Authors:  Sheila F Faraj; Alcides Chaux; Nilda Gonzalez-Roibon; Enrico Munari; Carla Ellis; Tina Driscoll; Mark P Schoenberg; Trinity J Bivalacqua; Ie-Ming Shih; George J Netto
Journal:  Hum Pathol       Date:  2014-07-23       Impact factor: 3.466

Review 8.  Is microsatellite instability a prognostic marker in gastric cancer? A systematic review with meta-analysis.

Authors:  Yoon Young Choi; Jung Min Bae; Ji Yeong An; In Gyu Kwon; In Cho; Hyun Beak Shin; Tanaka Eiji; Mohammad Aburahmah; Hyung-Il Kim; Jae-Ho Cheong; Woo Jin Hyung; Sung Hoon Noh
Journal:  J Surg Oncol       Date:  2014-04-15       Impact factor: 3.454

9.  Somatic mutations in the chromatin remodeling gene ARID1A occur in several tumor types.

Authors:  Siân Jones; Meng Li; D Williams Parsons; Xiaosong Zhang; Jelle Wesseling; Petra Kristel; Marjanka K Schmidt; Sanford Markowitz; Hai Yan; Darell Bigner; Ralph H Hruban; James R Eshleman; Christine A Iacobuzio-Donahue; Michael Goggins; Anirban Maitra; Sami N Malek; Steve Powell; Bert Vogelstein; Kenneth W Kinzler; Victor E Velculescu; Nickolas Papadopoulos
Journal:  Hum Mutat       Date:  2011-11-23       Impact factor: 4.878

10.  Promoter hypermethylation of ARID1A gene is responsible for its low mRNA expression in many invasive breast cancers.

Authors:  Xianyu Zhang; Qian Sun; Ming Shan; Ming Niu; Tong Liu; Bingshu Xia; Xiaoshuan Liang; Wei Wei; Shanshan Sun; Youxue Zhang; Xiaolong Sean Liu; Qingbin Song; Yanmei Yang; Yuyan Ma; Yang Liu; Long Yang; Yanlv Ren; Guoqiang Zhang; Da Pang
Journal:  PLoS One       Date:  2013-01-21       Impact factor: 3.240

View more
  6 in total

1.  Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8+ TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.

Authors:  Karolin Heinze; Tayyebeh M Nazeran; Sandra Lee; Pauline Krämer; Evan S Cairns; Derek S Chiu; Samuel Cy Leung; Eun Young Kang; Nicola S Meagher; Catherine J Kennedy; Jessica Boros; Friedrich Kommoss; Hans-Walter Vollert; Florian Heitz; Andreas du Bois; Philipp Harter; Marcel Grube; Bernhard Kraemer; Annette Staebler; Felix Kf Kommoss; Sabine Heublein; Hans-Peter Sinn; Naveena Singh; Angela Laslavic; Esther Elishaev; Alex Olawaiye; Kirsten Moysich; Francesmary Modugno; Raghwa Sharma; Alison H Brand; Paul R Harnett; Anna DeFazio; Renée T Fortner; Jan Lubinski; Marcin Lener; Aleksandra Tołoczko-Grabarek; Cezary Cybulski; Helena Gronwald; Jacek Gronwald; Penny Coulson; Mona A El-Bahrawy; Michael E Jones; Minouk J Schoemaker; Anthony J Swerdlow; Kylie L Gorringe; Ian Campbell; Linda Cook; Simon A Gayther; Michael E Carney; Yurii B Shvetsov; Brenda Y Hernandez; Lynne R Wilkens; Marc T Goodman; Constantina Mateoiu; Anna Linder; Karin Sundfeldt; Linda E Kelemen; Aleksandra Gentry-Maharaj; Martin Widschwendter; Usha Menon; Kelly L Bolton; Jennifer Alsop; Mitul Shah; Mercedes Jimenez-Linan; Paul Dp Pharoah; James D Brenton; Kara L Cushing-Haugen; Holly R Harris; Jennifer A Doherty; Blake Gilks; Prafull Ghatage; David G Huntsman; Gregg S Nelson; Anna V Tinker; Cheng-Han Lee; Ellen L Goode; Brad H Nelson; Susan J Ramus; Stefan Kommoss; Aline Talhouk; Martin Köbel; Michael S Anglesio
Journal:  J Pathol       Date:  2022-02-07       Impact factor: 9.883

2.  Case report: mismatch repair proficiency and microsatellite stability in gastric cancer may not predict programmed death-1 blockade resistance.

Authors:  Kuo-Hsing Chen; Chang-Tsu Yuan; Li-Hui Tseng; Chia-Tung Shun; Kun-Huei Yeh
Journal:  J Hematol Oncol       Date:  2016-03-24       Impact factor: 17.388

3.  Loss of ARID1A expression predicts poor survival prognosis in gastric cancer: a systematic meta-analysis from 14 studies.

Authors:  Lin Yang; Sheng Wei; Rongxian Zhao; Yingxing Wu; Hong Qiu; Huihua Xiong
Journal:  Sci Rep       Date:  2016-06-29       Impact factor: 4.379

4.  Clinicopathological Significance of Large Tumor Suppressor (LATS) Expression in Gastric Cancer.

Authors:  Myoung Won Son; Geum Jong Song; Si-Hyong Jang; Soon Auck Hong; Mee-Hye Oh; Ji-Hye Lee; Moo Jun Baek; Moon Soo Lee
Journal:  J Gastric Cancer       Date:  2017-12-26       Impact factor: 3.720

Review 5.  Unique characteristics of ARID1A mutation and protein level in gastric and colorectal cancer: A meta-analysis.

Authors:  Young-Sik Kim; Hoiseon Jeong; Jung-Woo Choi; Hwa Eun Oh; Ju-Han Lee
Journal:  Saudi J Gastroenterol       Date:  2017 Sep-Oct       Impact factor: 2.485

6.  Progression inference for somatic mutations in cancer.

Authors:  Leif E Peterson; Tatiana Kovyrshina
Journal:  Heliyon       Date:  2017-04-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.